Asahikawa Medical University Hospital
Hokkaido, Asahikawa 078-8510
1 studies enrolling now · 4 studies all time
What they study most
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Generalized Pustular Psoriasis, Hypertension, Palmoplantar Pustulosis, Palmoplantar Pustulosis (PPP)
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab — Stopped early
- Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis — Completed
- A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis — Completed